tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports
Want to see DE:DMP full AI Analyst Report?

Dermapharm Holding SE (DMP) Stock News & Sentiment

13 Followers
Is DMP a Buy, Before Earnings?
Premium
Pre-Earnings
Is DMP a Buy, Before Earnings?
6d ago
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
Premium
Ratings
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
11d ago
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
Premium
Ratings
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
2M ago
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
Premium
Ratings
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
2M ago
Dermapharm Holding SE: Navigating Transitional Challenges and Strategic Opportunities
Premium
Ratings
Dermapharm Holding SE: Navigating Transitional Challenges and Strategic Opportunities
9M ago
Balanced Hold Rating for Dermapharm Holding SE Amid Growth Prospects and Expansion Challenges
Premium
Ratings
Balanced Hold Rating for Dermapharm Holding SE Amid Growth Prospects and Expansion Challenges
9M ago
Dermapharm Holding SE: Strong Financial Resilience and Growth Potential Amid Strategic Adjustments
Premium
Ratings
Dermapharm Holding SE: Strong Financial Resilience and Growth Potential Amid Strategic Adjustments
9M ago
More DE:DMP News >

DMP News on the Web

Is DMP a Buy, Before Earnings?
TipRanks News
Bullish
€47.88 - That's What Analysts Think Dermapharm Holding SE (ETR:DMP) Is Worth After These Results
Simply Wall St
Neutral
Assessing Dermapharm Holding (XTRA:DMP) Valuation After Strong Q1 Results And Reaffirmed Outlook
Simply Wall St
Neutral
Berenberg Bank Sticks to Their Buy Rating for Dermapharm Holding SE (DMP)
TipRanks News
Bullish
Dermapharm Holding (XTRA:DMP) Margin Rebound Challenges Cautious Earnings Narratives In Q1 2026
Simply Wall St
Neutral
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
TipRanks News
Neutral
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
TipRanks News
Neutral
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
DE:DMP
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:DMP’s Media Buzz Sentiment?
1 articles about DE:DMP were published this week. In an average week, 1.25 articles are published.
    What is DE:DMP’s weekly average amount of articles?
    In an average week, 1.25 articles about DE:DMP are published.
      What is DE:DMP’s News Sentiment?
      100% of articles about DE:DMP were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week